NovaBay Pharmaceuticals, Inc. 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Nov 1, 2012
Insider Transaction Report
Form 4/AAmended
WU ROY J
SVP Bus & Corp Development
Transactions
- Award
Option (right to buy)
2012-09-26+25,000→ 319,902 totalExercise: $1.22From: 2013-09-26Exp: 2022-09-26→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the option shares vest and become exercisable on the first anniversary of the date of grant, and the balance of the option shares vest and become exercisable in a series of twelve (12) equal installments upon the completion of each three (3) months beginning September 26, 2013.
- [F2]Original Form 4 filed on 10/12/2012. This amendment is filed to correct the exercise price from $1.29 to $1.22 the closing price on the date the Compensation Committee approved the grant on September 26, 2012.
- [F3]Original Form 4 filed on 10/12/2012. This amendment is filed to correct the grant date from October 10, 2012 to September 26, 2012, the date the Compensation Committee approved the grant. There was a misunderstanding, management thought the grant will be subject to Board ratification at the Board's meeting on 10/10/2012, but the Board agreed that the grant date should be September 26 ,2012, the date the Compensation Committee approved the grant.